Jump to Main Content


ASH-SIE Abstract Achievement Award Recipients

The following individuals received the ASH-SIE Abstract Achievement Award

2023 Recipients

Enrico Attardi, MD
University of Rome Tor Vergata
Unraveling the Impact of 2022 Classifications on Secondary Acute Myeloid Leukemia: Assessing the True Qualification Power of Diagnostic Qualifiers

Luca Lanino, MD
Molecular Classification of Chronic Myelomonocytic Leukemia: Results of the Analysis of an International Cohort of 2,471 Patients

2022 Recipients

Laura Notarfranchi, MD
University of Parma
Ultra-Sensitive Assessment of Measurable Residual Disease (MRD) in Peripheral Blood (PB) of Multiple Myeloma (MM) Patients Using Bloodflow

Giovanni Marconi, MD
IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori “Dino Amadori”(IRST),
Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia

2021 Recipients

Annamaria Aprile, PhD
IRCCS San Raffaele Scientific Institute
Inhibition of Fibroblast Growth Factor-23 (FGF-23) Rescues Bone and Hematopoietic Stem Cell Niche Defects in Beta-Thalassemia, Uncovering the Missing Link between Hematopoiesis and Bone
Abstract #572

Enrica Federti, PhD
University of Verona
Nrf2 Plays a Key Role in Iron-Overload Cardiomyopathy
Abstract #3068

2020 Recipients

Luca Bertamini, MD
Poor Prognosis of Multiple Myeloma Predicted By High Levels of Circulating Plasma Cells Is Independent from Other High-Risk Features but Is Modulated By the Achievement of Minimal Residual Disease Negativity
Abstract #720

Raffaele Palmieri, MD
University of Rome Tor Vergata
Validation of ELN2017 Risk Stratification in a Post-Hoc Analysis of the Prospective Biomarker-Based Gimema AML1310 Protocol
Abstract #392

2019 Recipients

Pier Edoardo Rovatti, MD
IRCCS San Raffaele Scientific Institute
Exploiting an Anti-CD3/CD33 Bispecific Antibody to Redirect Donor T Cells Against HLA Loss Leukemia Relapses
Abstract #513

Chiara Magnanim, PhD
IRCCS San Raffaele Scientific Institute
Donor-Derived CD19 CAR Cytokine Induced Killer (CIK) Cells Engineered with Sleeping Beauty Transposon for Relapsed B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Abstract #200

2018 Recipients

Mariateresa Pettinato, MSc
IRCCS San Raffaele Scientific Institute
Inhibiting the Immunophilin FKBP12: A Potential Therapeutic Approach to Iron Overload/Low Hepcidin Disorders
Abstract #2333

Francesco Maura
University of Milan
Whole Genome Sequencing Reveals Recurrent Structural Driver Events in Peripheral T-Cell Lymphomas Not Otherwise Specified
Abstract #109

2017 Recipients

Antonella Nai, PhD
IRCCS San Raffaele Scientific Institute
The Macrophage Nuclear Receptor Coactivator 4 Counteracts Iron-Deficiency Anemia
Abstract #224

Giorgia Federico, PhD
University of Naples Federico II
NCOA4 Links Iron Bioavailability to DNA Metabolism
Abstract #223